A
10.57
0.21 (2.03%)
| Penutupan Terdahulu | 10.36 |
| Buka | 10.40 |
| Jumlah Dagangan | 532,172 |
| Purata Dagangan (3B) | 594,998 |
| Modal Pasaran | 435,667,744 |
| Harga / Pendapatan (P/E Ke hadapan) | 96.15 |
| Harga / Jualan (P/S) | 1.40 |
| Harga / Buku (P/B) | 2.44 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 2 Apr 2026 |
| Margin Keuntungan | -11.62% |
| Margin Operasi (TTM) | -4.53% |
| EPS Cair (TTM) | -0.830 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 12.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.54% |
| Nisbah Semasa (MRQ) | 2.21 |
| Aliran Tunai Operasi (OCF TTM) | -10.13 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.21 M |
| Pulangan Atas Aset (ROA TTM) | -5.03% |
| Pulangan Atas Ekuiti (ROE TTM) | -17.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Menurun | |
| Stok | AngioDynamics, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.1
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.13 |
|
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 6.84% |
| % Dimiliki oleh Institusi | 92.87% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bastion Asset Management Inc. | 30 Sep 2025 | 1,264,003 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Jan 2026 | Pengumuman | AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability |
| 23 Dec 2025 | Pengumuman | AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026 |
| 22 Dec 2025 | Pengumuman | AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| 27 Oct 2025 | Pengumuman | AngioDynamics to Participate in the UBS Global Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |